AVLN peer analysis
Avalyn Pharma (AVLN) against its competitors: price, today's move, 1-year return and market value side by side.
AVLN and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| GYRE Gyre Therapeutics | $4.65 | -2.31% | -35.51% | $493.06M |
| INSM Insmed | $119.51 | 2.94% | -37.00% | $26.22B |
| MNKD MannKind | $4.24 | 1.19% | -24.69% | $1.36B |
| PULM Pulmatrix | $1.35 | -1.81% | -71.64% | $4.95M |
| VCRE Vicore Pharma | $11.27 | 8.37% | – | $318.35M |
| AVLN Avalyn Pharma | $31.18 | 5.69% | – | $1.38B |
- AVLN's peers: GYRE (Gyre Therapeutics), INSM (Insmed), MNKD (MannKind), PULM (Pulmatrix), VCRE (Vicore Pharma).
Updated 2026-11-11 00:49 UTC